Gene: Tnfrsf14
Official Full Name: tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)provided by MGI
Gene Summary: Predicted to enable cytokine binding activity and ubiquitin protein ligase binding activity. Acts upstream of or within several processes, including defense response to bacterium; negative regulation of CD4-positive, alpha-beta T cell proliferation; and positive regulation of macromolecule metabolic process. Located in external side of plasma membrane. Is expressed in liver lobe. Orthologous to human TNFRSF14 (TNF receptor superfamily member 14). [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00817 | Tnfrsf14 Knockout cell line (MC38) | Mouse | Tnfrsf14 | 1:2-1:4 | Negative | Online Inquiry |
Tnfrsf14 Gene Knockout Cell Lines are genetically modified cell lines created to specifically disrupt the Tnfrsf14 gene, which encodes the tumor necrosis factor receptor superfamily member 14, also known as LIGHT receptor or HVEM. This gene plays a crucial role in immune regulation and cancer biology, influencing pathways involved in cell survival, proliferation, and apoptosis. By utilizing these knockout cell lines, researchers can effectively study the implications of Tnfrsf14 loss on cellular signaling, immune response, and tumor microenvironment interactions.
The key function of Tnfrsf14 knockout cell lines lies in their ability to elucidate the biological consequences arising from the absence of this receptor. Mechanistically, loss of Tnfrsf14 can alter the activation of NF-κB and MAPK signaling pathways, thereby providing insights into how immune evasion by tumors may occur. This is particularly important for dissecting tumor-immune interactions and understanding the potential therapeutic avenues for immunotherapy.
The scientific importance of these cell lines extends into both basic and translational research applications. They serve as powerful tools for investigating how Tnfrsf14 influences dendritic cell maturation and T cell activation, thus aiding in the development of novel immunotherapeutic strategies against cancer. Researchers can also utilize these cell lines to assess the potential efficacy of new drugs targeting the Tnfrsf14 pathway.
Compared to other genetic models, our Tnfrsf14 Gene Knockout Cell Lines offer high specificity and reproducibility. They are designed with advanced CRISPR-Cas9 gene-editing technology, ensuring precise gene disruption and maintaining cell viability and functionality. This specificity allows for a clearer interpretation of experimental results, minimizing off-target effects that can confound research outcomes.
This product is invaluable for researchers and clinicians aiming to enhance their understanding of immune mechanisms and cancer treatment. The use of Tnfrsf14 knockout cell lines can accelerate the identification of therapeutic targets, leading to innovative and effective treatment options.
Our company prides itself on its commitment to providing high-quality biological products supported by rigorous scientific validation and expertise in genetic engineering. By choosing our Tnfrsf14 Gene Knockout Cell Lines, researchers can confidently advance their research initiatives with superior scientific integrity and support.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.